Accepting PhD Students

PhD projects

<a href="https://www.monash.edu/medicine/research/supervisorconnect" onclick="target='_blank';">https://www.monash.edu/medicine/research/supervisorconnect</a>

20022023

Research activity per year

If you made any changes in Pure these will be visible here soon.

Personal profile

Biography

Associate Professor Cornelia Landersdorfer leads the Antimicrobial Pharmacokinetics, Pharmacodynamics and Dosage regimen optimisation research group at the Monash Institute of Pharmaceutical Sciences. She obtained her PhD in Pharmaceutical Sciences from the University of Wuerzburg (2006), completed postdoctoral studies in PK/PD modelling at the State University of New York (SUNY), and worked as a Scientist at Ordway Research Institute & the Institute for Clinical Pharmacodynamics (ICPD), NY. In 2011 she joined MIPS. She has since been awarded an NHMRC Career Development Fellowship and the ASCEPT Denis Wade J&J New Investigator Award. In 2018, Cornelia received the prestigious Georgina Sweet Award for Women in Quantitative Biomedical Science. In 2020 she was awarded the Faculty of Pharmacy and Pharmaceutical Sciences Research Impact award. She has led and is leading NHMRC Project and Ideas grants and is the Project Director of a large NIH clinical PK modelling contract.Associate Professor - Centre for Medicine Use and Safety.

In 2020, Cornelia joined the Monash Center to Impact AMR as a founding member and provides expert advice to our Research and Industry Strategy, Clinical Evaluation, and Training and Inclusion workkng groups. 

Related Links: 

Research interests

Antibiotic mono- and combination therapy to achieve synergistic bacterial killing and prevent resistance

Population pharmacokinetics, pharmacodynamics, and optimised dosage regimens of anti-infectives and other agents

Mechanism-based mathematical modelling

Tissue penetration into bone and other tissues

Mechanism-based population modelling of the glucose-insulin system, drug effects and disease progression in type 2 diabetes

Renal elimination mechanisms

Monash teaching commitment

BPS2041 Drug delivery and pharmacokinetics (second year Pharm Sci) - Unit coordinator and teaching pharmacokinetics

BPS3332 Applied pharmacokinetics/pharmacodynamics (third year Pharm Sci) - Unit coordinator and teaching pharmacokinetics/pharmacodynamics

Coordinating the CMUS PhD student training (CMUS HDR modules)

PHR1022 How Medicines Work II (first year Pharmacy) - teaching pharmacokinetics, pharmacogenomics, pharmacokinetics/pharmacodynamics

PhD student training in workshops on mechanism-based, population pharmacokinetic / pharmacodynamic modelling and simulation

Teaching applications of mechanism-based modelling to pharmaceutical industry

Expertise related to UN Sustainable Development Goals

In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):

  • SDG 3 - Good Health and Well-being

Education/Academic qualification

Pharmaceutical Sciences, PhD, Modern pharmacokinetic / pharmacodynamic techniques to study physiological mechanisms of pharmacokinetic drug-drug interactions and disposition of antibiotics and to assess clinical relevance, Julius-Maximilians-Universität Würzburg (University of Wurzburg)

20022006

Award Date: 26 Sept 2006

Pharmacy and Pharmaceutical Sciences, BPharm, Universitat Regensburg (University of Regensburg)

19962001

External positions

Adjunct Associate Professor, University at Buffalo, State University of New York

15 Aug 2009 → …

Research area keywords

  • Pharmacokinetics
  • Pharmacodynamics
  • Antimicrobial resistance
  • Mathematical modelling
  • Pharmacokinetics and Pharmacodynamics of Antibiotics
  • Pseudomonas aeruginosa

Collaborations and top research areas from the last five years

Recent external collaboration on country/territory level. Dive into details by clicking on the dots or